Christoph B Olivier

Cardiologist and clinician scientist @UHZ_UNIFreiburg; personalized antithrombotic therapy – trial methodology – digital health solutions

[Christoph B Olivier @antithrombotic]

Ever designed a CV trial and overestimated the event rate or effect size?
You are not alone! Despite careful evaluation overestimation may occur. We analyzed data from 344 CV trials published @Jama @NEJM @thelancet
https://t.co/LXaTcE6mPg

[Philipp Breitbart @Kardiophil]

🏥 Seit 2019 durchgängig zertifizierter @YoungDgk Fortbildungsstandort: Die Klinik für Kardiologie & Angiologie am @UHZ_UNIFreiburg der @Uniklinik_Fr bietet strukturierte Weiterbildung mit Top-Fallzahlen, Mentoring & Zusatzqualifikationen. Alle Infos 👉 https://t.co/UnkMXm5GLa

[ESC WG Thrombosis Chairperson @ESCWGThrombosis]

A joint effort by the #ESC WG on Cardiovascular Pharmacotherapy and the WG on #Thrombosis!
Discover the latest consensus statement on managing #antithrombotic therapy at #body size extremes.
A must-read for clinicians and researchers! #personalized care
https://t.co/EL3U1FQ65T

[Christoph B Olivier @antithrombotic]

Open access:

https://t.co/LXaTcE6UEO

[TCTMD @TCTMD]

For this Quick Takes, Christoph Olivier (@antithrombotic) takes a closer look at clinical trial design, specifically at how accurate estimates of event rate and effect size are in trials. Watch the full video here: https://t.co/TzChprYFmt

[Christoph B Olivier @antithrombotic]

@TheMahaf @dirkwestermann @meerpohl @LukasHegerMD @HeartBobH @DLBHATTMD @drroxmehran @CMichaelGibson @leftbundle @FaRodriguezMD @RenatoDLopes1 @thiele_holger @texhern @JAMANetworkOpen

[Christoph B Olivier @antithrombotic]

Ever designed a CV trial and overestimated the event rate or effect size?
You are not alone! Despite careful evaluation overestimation may occur. We analyzed data from 344 CV trials published @Jama @NEJM @thelancet
https://t.co/LXaTcE6mPg

[AG 19 - Kardiovask. Hämostase/antithromb. Therapie @AG19_DGK]

8th Atherothrombosis Winterschool in Würzburg where young scientists and experienced researches came together! We thank DGTI for the cooperation and colleagues from Austria and Switzerland as well as everyone else that joined for the fantastic meeting!
@DGK_org @antithrombotic

[Lucas Bacmeister @LucasBacmeister]

🤰🏽🫀Preeclampsia shares numerous risk factors with CV disease and women w/ PE have higher CV burden during midlife.

Let me introduce you to how we could show that high-sens Trop I during pregnancy predicts PE vice versa - a 🧵

[Christoph B Olivier @antithrombotic]

An die Rechner, fertig, los: Abstract 👉🏻 8. Atherothrombosis Winterschool!

@DGK_org @YoungDgk @AG4_DGK @AGIKinterv @petzold_tobias @dirkwestermann @HilgendorfIngo @Kardiophil @UHZ_UNIFreiburg @imit_freiburg @Uniklinik_Fr

[Christoph B Olivier @antithrombotic]

@YoungDgk @Kardiophil @petzold_tobias @WinkelsLab @TogeislerMD @Hannah_Billig_ @AndreasZietzer @hauke_horstmann @VitaliKoch @V_Ehreiser Mark your calendar for the 8th atherothrombosis #AG19winterschool

12-13JAN2024

@DGK_org @YoungDgk

[Christoph B Olivier @antithrombotic]

@YoungDgk @Kardiophil @petzold_tobias @WinkelsLab @TogeislerMD @Hannah_Billig_ @AndreasZietzer @hauke_horstmann @VitaliKoch @V_Ehreiser 🎯This joined meeting #AG19 with @YoungDgk had it all:

impactful research (by young researchers!),

interaction for promising cooperation,

tips from experienced researchers for a successful career, and

engaged conversations.

Grateful to see the next generation grow!

[Holger Winkels @WinkelsLab]

@YoungDgk Vielen Dank für die Möglichkeit meine Erfahrungen während meines Postdocs und den Weg dahin teilen zu können bei der sehr spannenden #AG19WinterSchool, #AG19 and @YoungDgk
Ich hab mich über die Interaktion mit allen sehr gefreut.

[Young DGK @YoungDgk]

Die Abstract-Frist wurde bis zum 30.11. verlängert, also ran an die Computer🧑‍💻

👋🏻 See you in Breisach

@antithrombotic @petzold_tobias @UHZ_UNIFreiburg @TogeislerMD

[Young DGK @YoungDgk]

Die Atherothrombosis Winterschool findet dieses Mal als Joint Meeting von AG19 und Young DGK statt 🤓

➡️Einblicke in Atherothrombose, young Sessions & Networking inklusive

🗓️ 13./14.01.2023, Breisach am Rhein
✉️ Abstracts einreichen bis 23.11.

https://t.co/OONgC2NnJ7

@DGK_org

[Kenneth Mahaffey @TheMahaf]

Thanks to all who contribute to evidence generation to improve human health through clinical trials!!! @StanfordDeptMed @SCCR_Stanford @HeartBobH @texhern @CMichaelGibson

[Christoph B Olivier @antithrombotic]

38 young researchers @YoungDgk presented results from cooperations with 100s of researchers, ~50 institutions, 5 countries and made the 6th #atherothrombosis meeting a success! Inspiring science and lots of fun.

[Christoph B Olivier @antithrombotic]

Thanks to all presenters, participants, and moderators for contributing to the 6th #atherothrombosis meeting AG19 @DGK_org with our friends from @AG4_DGK

[Hannah Billig @Hannah_Billig_]

Congratulations to @ElenaRepges from @UniklinikBonn and Shaza El-Nemr from @Cardio_LMU on winning prizes for their presentations at the #AG19WinterSchool 🏆🌟
#welldeserved

@DGK_org @AG4_DGK @YoungDgk
@antithrombotic @TogeislerMD

[Christoph B Olivier @antithrombotic]

@spodcast_scf ✋🏻

[Christoph B Olivier @antithrombotic]

@FaRodriguezMD @HeartBobH @StanfordDeptMed @StanfordMed @StanCVFellows @StanfordCVI @AshishSarraju @leftbundle @TheMahaf @TYWangMD @AnnMarieNavar @vbluml @joshuawknowles @NeilKalwani @boussard @hmkyale @kewatson This is well deserved. Congrats Fatima!

[Christoph B Olivier @antithrombotic]

@dirkwestermann @Uniklinik_Fr @UKEHamburg Welcome to @Uniklinik_Fr @Herzzentrum! Looking forward to your leadership in research, patient care, and teaching. Exciting opportunities.